News and Press Releases

Headlands Research Announces Fifth Research Site under Partnership with Pfizer to Improve Diversity in Clinical Trials

Headlands Research Orlando satisfies the organisations’ commitment to create multiple research sites aimed at increasing health equity in clinical research 28 March 2024 -- California, US -- Headlands Research, a...

Category: Clinical Trials
Posted: April 2, 2024

130 John F Kennedy Dr STE 203 Lake Worth, FL 33462

Bio-Rad Launches First Ultrasensitive Multiplexed Digital PCR Assay for Breast Cancer Mutation Detection in Clinical Research

Highly Sensitive and Multiplexed Assay for the Detection, Discrimination and Quantification of Key Mutations in ESR1 Gene for Breast Cancer, Developed for Bio-Rad’s QX600 Droplet Digital PCR System 2 April...

Category: Clinical Trials
Posted: April 2, 2024

Bio-Rad Laboratories Ltd. The Junction Station Road Watford Hertfordshire WD17 1ET

Scope of Industry Risk-Based Quality Management (RBQM) Adoption Revealed

CluePoints, the Tufts Center for the Study of Drug Development and PwC publish Comprehensive Assessment of RBQM Adoption in Clinical Trials 2 April 2024 -- Pennsylvania, US -- A comprehensive...

Category: Other, Pharmaceutical
Posted: April 2, 2024

1000 Continental Drive, Suite 240, King of Prussia, PA 19406

X‑Chem Adds Chief Technology Officer to Bolster Its Digital Drug Discovery Strategy 

2 April 2024 -- Massachusetts, US -- X-Chem, the leading provider of innovative solutions in early-stage drug discovery, today announced the addition of Dr Erin Davis as chief technology officer....

Category: Drug Discovery
Posted: April 2, 2024

100 Beaver Street Waltham, MA 02453

Nonacus launches test for comprehensive genomic profiling, integrated with bioinformatics and analysis software

2 April 2024 -- Birmingham, UK -- Genetic testing company, Nonacus, has launched GALEAS Tumor, a next generation sequencing (NGS) test that provides comprehensive genomic profiling of tumours, allowing clinicians...

Category: Biotechnology
Posted: April 2, 2024

Unit 5, Quinton Business Park, 11 Ridgeway, Quinton, Birmingham B32 1AF, United Kingdom

Bora Pharmaceuticals completes the acquisition of Upsher-Smith

Acquisition expands Bora’s North American footprint with first US manufacturing site  1 April 2024 -- Taipei, Taiwan -- Bora Pharmaceuticals today announced that it has completed the acquisition of Upsher-Smith Laboratories,...

Category: BioManufacturing
Posted: April 1, 2024

6F., No. 2, Aly. 36, Ln. 26, Ruiguang Rd., Neihu District, Taipei City, 114 Taiwan

Touchlight Awarded Tender to Supply Enzymatic dbDNA to CPI’s RNA Centre of Excellence

28 March 2024 -- Hampton, UK -- Touchlight, an innovation-driven CDMO enabling the development of genetic medicines with its doggybone DNA (dbDNA) technology and leaders in enzymatic DNA production, is...

Category: Biotechnology
Posted: March 28, 2024

Morelands & Riverdale Buildings Lower Sunbury Road Hampton TW12 2ER

Aragen operationalises first phase of its Biologics manufacturing facility in India

Executes the first project for developing and manufacturing a novel anticancer mAb 28 March 2024 – Hyderabad, India – Aragen, a leading Contract Research Development and Manufacturing Organisation (CRDMO) for...

Category: Biotechnology, Drug Discovery
Posted: March 28, 2024

Leading CDMO PCI Pharma Services Releases Inaugural Comprehensive ESG Report

Highlights include environmental goals based on climate science, workforce empowerment, focus on local partnerships and supply chain resiliency 27 March 2024 -- Pennsylvania, US -- PCI Pharma Services, a leading...

Category: Drug Discovery, Manufacturing and Packing
Posted: March 27, 2024

3001 Red Lion Road, Philadelphia, PA 19114, USA

Indegene acquires Trilogy Writing & Consulting GmbH, a medical writing consultancy

27 March 2024 -- Princeton, US, and Frankfurt, Germany -- Indegene, a digital-first, life sciences commercialisation company, announced the acquisition of Trilogy Writing & Consulting GmbH (Trilogy), a global provider...

Category: Pharmaceutical
Posted: March 27, 2024

Indegene, Inc. 150 College Rd W Suite 104 Princeton NJ 08540

Bio-Rad launches validated antibodies for Rare Cell and Circulating Tumour Cell Enumeration

Antibodies Validated for Use with Bio-Rad’s Celselect Slides Enumeration Stain Kits to Enable Immunostaining of Captured Circulating Tumor Cells in Liquid Biopsy Samples 26 March 2024 – Hercules, CA, US...

Category: Biotechnology, Drug Discovery
Posted: March 26, 2024

Bio-Rad Laboratories Ltd. The Junction Station Road Watford Hertfordshire WD17 1ET

SMC Ltd Announces Expansion of Sterile Fill Finish Capabilities, Unveiling State-of-the-Art Facility in North Carolina, US

26 March 2024 -- Wisconsin, US -- SMC Ltd, the worldwide contract manufacturer of single use and disposable medical devices, has today announced the acquisition of an end-to-end fill/finish facility...

Category: Manufacturing and Packing
Posted: March 26, 2024

330 SMC Drive Somerset WI 54025 U.S.A

One2Treat launches ground-breaking treatment-decision approach to clinical research and market access analysis

One2Treat reflects patient priorities in a single comprehensive treatment evaluation, reducing trial sample size and accelerating patient access to new treatments 26 March 2024 -- Brussels, Belgium -- One2Treat, a...

Category: Clinical Trials, Pharmaceutical
Posted: March 26, 2024

Rue Emile Francqui, 1-1435 Mont-Saint-Guibert, Belgium

Shockwave Medical to Participate in the 23rd Annual Needham Virtual Healthcare Conference

26 March 2024 -- California, US -- Shockwave Medical, a pioneer in the development and commercialisation of transformational technologies for the treatment of cardiovascular disease, announced today that the company...

Category: Biotechnology
Posted: March 26, 2024

5403 Betsy Ross Drive Santa Clara, CA, 95054 - USA

Novo Nordisk to acquire Cardior Pharmaceuticals and strengthenpipeline in cardiovascular disease

25 March, 2024 -- Bagsværd, Denmark, and Hannover, Germany -- Novo Nordisk and CardiorPharmaceuticals today announced that Novo Nordisk has agreed to acquire Cardior for up to€1.025bn, including an upfront...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: March 26, 2024

Novo Nordisk A/S Novo Allé, 2880 Bagsvaerd Denmark